LBRX LB PHARMACEUTICALS INCcompanySEC Filings & Insider Trading Activity 2026
Latest LB PHARMACEUTICALS INC (LBRX) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 26, 2026, a 10-Q quarterly report filed on May 12, 2026, an 8-K current report filed on July 29, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for LB PHARMACEUTICALS INC (LBRX) (SEC CIK 1691082), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on LB PHARMACEUTICALS INC
Ask AI about LBRX filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting LBRX positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on LBRX.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of LB PHARMACEUTICALS INC (LBRX) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate LBRX share value held by 13F filers tracked by SignalX, by quarter.
- State Street Corp+254.3K (+102%)
- BlackRock+231.9K (+10%)
- Goldman Sachs Group+60.7K (+20%)
- Morgan Stanley+22.6K (+92%)
- Northern Trust+10.4K (+7%)
- Ameriprise Financial85.2K (-44%)
- Bank of America Corp27.1K (-62%)
- Wells Fargo & Co13.7K (-61%)
- Millennium Management+137.0K
- PNC Financial Services+145
- JPMorgan Chase & Co−1.61M
- Vanguard Group Inc−1.11M
- Invesco Ltd−11.0K
Source: 13F-HR filings on SEC EDGAR (aggregated from 42 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest LBRX SEC filings in 2026?
LB PHARMACEUTICALS INC (LBRX) has filed a 10-K annual report on March 26, 2026, a 10-Q quarterly report on May 12, 2026, an 8-K current report on July 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did LBRX file its most recent 10-K annual report?
LB PHARMACEUTICALS INC (LBRX) filed its most recent 10-K annual report on March 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view LBRX 10-Q quarterly reports?
LB PHARMACEUTICALS INC (LBRX)'s most recent 10-Q quarterly report was filed on May 12, 2026. SignalX displays every LBRX 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has LBRX filed recently?
LB PHARMACEUTICALS INC (LBRX)'s most recent 8-K was filed on July 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find LBRX insider trading activity (Form 4)?
SignalX aggregates every LBRX Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does LBRX file with the SEC?
LB PHARMACEUTICALS INC (LBRX) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new LBRX filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for LB PHARMACEUTICALS INC (LBRX).
What is LBRX's SEC CIK number?
LB PHARMACEUTICALS INC (LBRX)'s SEC CIK (Central Index Key) number is 1691082. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1691082 to look up all LBRX filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of LB PHARMACEUTICALS INC SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 12+ filings.